In this study, we analysed the potential effects of Aurora-A kinase inhibition on tumour response to IR using RNAi or a novel selective inhibitor of Aurora kinases, PHA680632, which strongly inhibits the phosphorylation of T288 Aurora-A. The gene discussed is AURKA; the disease is neoplasm.